Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Talking Tom & Friends and Miraculous® launch a print-on-demand merch line on Spreadshirt, moving their viral digital crossover into the physical world.
-
Dealers and media partners are invited to visit PureCars at NADA to see how first-party data, AI, and unified engagement are reshaping dealership m
-
Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15...
-
HALIFAX, Nova Scotia, 28 janv. 2026 (GLOBE NEWSWIRE) -- Rogers Communications a annoncé aujourd’hui qu’elle inclut désormais la Connexion satellite de Rogers dans tous ses forfaits 5G+ pour toute sa...
-
HALIFAX, Nova Scotia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Rogers Communications today announced that all customers in Atlantic Canada on all 5G+ plans now have Rogers Satellite included at no extra...
-
Breeze Expands Its Nice, Nonstop Service to New Destinations, Including Nassau, Bahamas, This Summer
-- Fares Start from $99* One Way -- SALT LAKE CITY, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Breeze Airways, the premium leisure carrier providing affordable, direct flights from underserved markets,...
-
• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ development of a single-molecule assay for measuring...
-
HTVRONT helps makers turn everyday items into meaningful Valentine’s gifts with hands-on creativity and beginner-friendly automation.
-
TORONTO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cority, the global leader in EHS and sustainability software, today announced its expansion into Saudi Arabia, supporting organizations operating in one of...
-
CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases,...